ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2019

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients.

Jihong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.